guest ::
| Home > Publications Database > N-methyl-D-aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunit. > print |
| Home > Publications Database > N-methyl-D-aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunit. > print |
| 001 | 140669 | ||
| 005 | 20250606100745.0 | ||
| 024 | 7 | _ | |a 10.1002/ana.25460 |2 doi |
| 024 | 7 | _ | |a pmid:30843274 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC6593665 |2 pmc |
| 024 | 7 | _ | |a 0364-5134 |2 ISSN |
| 024 | 7 | _ | |a 1531-8249 |2 ISSN |
| 024 | 7 | _ | |a altmetric:56715664 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-06991 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Wenke, Nina Kerstin |0 P:(DE-2719)2811131 |b 0 |e First author |u dzne |
| 245 | _ | _ | |a N-methyl-D-aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunit. |
| 260 | _ | _ | |a Hoboken, NJ |c 2019 |b Wiley-Blackwell |
| 264 | _ | 1 | |3 online |2 Crossref |b Wiley |c 2019-04-02 |
| 264 | _ | 1 | |3 print |2 Crossref |b Wiley |c 2019-05-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1749124421_15769 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is the most common autoimmune encephalitis related to autoantibody-mediated synaptic dysfunction. Cerebrospinal fluid-derived human monoclonal NR1 autoantibodies showed low numbers of somatic hypermutations or were unmutated. These unexpected germline-configured antibodies showed weaker binding to the NMDAR than matured antibodies from the same patient. In primary hippocampal neurons, germline NR1 autoantibodies strongly and specifically reduced total and synaptic NMDAR currents in a dose- and time-dependent manner. The findings suggest that functional NMDAR antibodies are part of the human naïve B cell repertoire. Given their effects on synaptic function, they might contribute to a broad spectrum of neuropsychiatric symptoms. Ann Neurol 2019;85:771-776. |
| 536 | _ | _ | |a 342 - Disease Mechanisms and Model Systems (POF3-342) |0 G:(DE-HGF)POF3-342 |c POF3-342 |f POF III |x 0 |
| 536 | _ | _ | |a 341 - Molecular Signaling (POF3-341) |0 G:(DE-HGF)POF3-341 |c POF3-341 |f POF III |x 1 |
| 542 | _ | _ | |i 2019-04-02 |2 Crossref |u http://creativecommons.org/licenses/by-nc/4.0/ |
| 542 | _ | _ | |i 2019-04-02 |2 Crossref |u http://doi.wiley.com/10.1002/tdm_license_1.1 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Anti-N-Methyl-D-Aspartate Receptor Encephalitis: blood |2 MeSH |
| 650 | _ | 2 | |a Anti-N-Methyl-D-Aspartate Receptor Encephalitis: pathology |2 MeSH |
| 650 | _ | 2 | |a Autoantibodies: blood |2 MeSH |
| 650 | _ | 2 | |a HEK293 Cells |2 MeSH |
| 650 | _ | 2 | |a Hippocampus: chemistry |2 MeSH |
| 650 | _ | 2 | |a Hippocampus: metabolism |2 MeSH |
| 650 | _ | 2 | |a Hippocampus: pathology |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Mice |2 MeSH |
| 650 | _ | 2 | |a Neurons: chemistry |2 MeSH |
| 650 | _ | 2 | |a Neurons: metabolism |2 MeSH |
| 650 | _ | 2 | |a Protein Binding: physiology |2 MeSH |
| 650 | _ | 2 | |a Protein Structure, Secondary |2 MeSH |
| 650 | _ | 2 | |a Receptors, N-Methyl-D-Aspartate: blood |2 MeSH |
| 650 | _ | 2 | |a Receptors, N-Methyl-D-Aspartate: chemistry |2 MeSH |
| 700 | 1 | _ | |a Kreye, Jakob |0 P:(DE-2719)2811468 |b 1 |u dzne |
| 700 | 1 | _ | |a Andrzejak, Ewa |0 P:(DE-2719)2811708 |b 2 |u dzne |
| 700 | 1 | _ | |a Casteren, Adriana |0 P:(DE-2719)2814218 |b 3 |u dzne |
| 700 | 1 | _ | |a Leubner, Jonas |0 P:(DE-2719)2811472 |b 4 |u dzne |
| 700 | 1 | _ | |a Murgueitio, Manuela S |0 P:(DE-HGF)0 |b 5 |
| 700 | 1 | _ | |a Reincke, S Momsen |0 P:(DE-2719)2812526 |b 6 |u dzne |
| 700 | 1 | _ | |a Secker, Christopher |0 P:(DE-2719)9000380 |b 7 |u dzne |
| 700 | 1 | _ | |a Schmidl, Lars |0 P:(DE-HGF)0 |b 8 |
| 700 | 1 | _ | |a Geis, Christian |0 P:(DE-HGF)0 |b 9 |
| 700 | 1 | _ | |a Ackermann, Frauke |0 P:(DE-2719)2810967 |b 10 |u dzne |
| 700 | 1 | _ | |a Nikolaus, Marc |0 P:(DE-HGF)0 |b 11 |
| 700 | 1 | _ | |a Garner, Craig C |0 P:(DE-2719)2810922 |b 12 |u dzne |
| 700 | 1 | _ | |a Wardemann, Hedda |0 P:(DE-HGF)0 |b 13 |
| 700 | 1 | _ | |a Wolber, Gerhard |0 P:(DE-HGF)0 |b 14 |
| 700 | 1 | _ | |a Prüss, Harald |0 P:(DE-2719)2810931 |b 15 |e Last author |u dzne |
| 773 | 1 | 8 | |a 10.1002/ana.25460 |b : Wiley, 2019-04-02 |n 5 |p 771-776 |3 journal-article |2 Crossref |t Annals of Neurology |v 85 |y 2019 |x 0364-5134 |
| 773 | _ | _ | |a 10.1002/ana.25460 |g Vol. 85, no. 5, p. 771 - 776 |0 PERI:(DE-600)2037912-2 |n 5 |q 85:5<771 - 776 |p 771-776 |t Annals of neurology |v 85 |y 2019 |x 0364-5134 |
| 856 | 7 | _ | |2 Pubmed Central |u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593665 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/140669/files/DZNE-2020-06991.pdf |y OpenAccess |
| 856 | 4 | _ | |u https://pub.dzne.de/record/140669/files/DZNE-2020-06991.pdf?subformat=pdfa |x pdfa |y OpenAccess |
| 909 | C | O | |o oai:pub.dzne.de:140669 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2811131 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2811468 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2811708 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)2814218 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)2811472 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 6 |6 P:(DE-2719)2812526 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 7 |6 P:(DE-2719)9000380 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 10 |6 P:(DE-2719)2810967 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 12 |6 P:(DE-2719)2810922 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 15 |6 P:(DE-2719)2810931 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-342 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Disease Mechanisms and Model Systems |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-341 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Molecular Signaling |x 1 |
| 914 | 1 | _ | |y 2019 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-30 |
| 915 | _ | _ | |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0 |0 LIC:(DE-HGF)CCBYNC4 |2 HGFVOC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-30 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-30 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ANN NEUROL : 2021 |d 2022-11-30 |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b ANN NEUROL : 2021 |d 2022-11-30 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-30 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2022-11-30 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-30 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-30 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2022-11-30 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2022-11-30 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-30 |
| 920 | 1 | _ | |0 I:(DE-2719)1810003 |k AG Prüß |l Autoimmune Encephalopathies |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1810001 |k AG Garner |l Synaptopathy |x 1 |
| 920 | 1 | _ | |0 I:(DE-2719)1813004 |k AG Ackermann |l Astrocyte - Synapse Interactions |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1810003 |
| 980 | _ | _ | |a I:(DE-2719)1810001 |
| 980 | _ | _ | |a I:(DE-2719)1813004 |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | 1 | _ | |a FullTexts |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/S1474-4422(08)70224-2 |2 Crossref |o 10.1016/S1474-4422(08)70224-2 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/S1474-4422(12)70310-1 |2 Crossref |o 10.1016/S1474-4422(12)70310-1 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/ana.24083 |2 Crossref |o 10.1002/ana.24083 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/ana.23689 |2 Crossref |o 10.1002/ana.23689 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/acn3.444 |2 Crossref |o 10.1002/acn3.444 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/brain/awu310 |2 Crossref |o 10.1093/brain/awu310 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/brain/aww208 |2 Crossref |o 10.1093/brain/aww208 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.jim.2007.09.017 |2 Crossref |o 10.1016/j.jim.2007.09.017 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1126/science.1086907 |2 Crossref |o 10.1126/science.1086907 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1126/sciimmunol.aap8029 |2 Crossref |o 10.1126/sciimmunol.aap8029 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00415-018-9042-1 |2 Crossref |o 10.1007/s00415-018-9042-1 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/brain/awv324 |2 Crossref |o 10.1093/brain/awv324 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.3389/fnsyn.2015.00016 |2 Crossref |o 10.3389/fnsyn.2015.00016 |
| 999 | C | 5 | |y 2012 |2 Crossref |t AMBER 12 |o Case DA AMBER 12 2012 |
| 999 | C | 5 | |y 1961 |2 Crossref |o Helmreich E 1961 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/eji.1830160206 |2 Crossref |o 10.1002/eji.1830160206 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/ana.24189 |2 Crossref |o 10.1002/ana.24189 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1172/JCI78083 |2 Crossref |o 10.1172/JCI78083 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.coi.2008.09.001 |2 Crossref |o 10.1016/j.coi.2008.09.001 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/ana.25173 |2 Crossref |o 10.1002/ana.25173 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/brain/awy010 |2 Crossref |o 10.1093/brain/awy010 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1001/jamaneurol.2014.488 |2 Crossref |o 10.1001/jamaneurol.2014.488 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1097/PGP.0b013e31824a1de2 |2 Crossref |o 10.1097/PGP.0b013e31824a1de2 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1242/dmm.020727 |2 Crossref |o 10.1242/dmm.020727 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1001/jamaneurol.2015.2188 |2 Crossref |o 10.1001/jamaneurol.2015.2188 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1097/00005072-198701000-00008 |2 Crossref |o 10.1097/00005072-198701000-00008 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1161/STROKEAHA.114.008323 |2 Crossref |o 10.1161/STROKEAHA.114.008323 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1084/jem.20160201 |2 Crossref |o 10.1084/jem.20160201 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1523/JNEUROSCI.0064-12.2012 |2 Crossref |o 10.1523/JNEUROSCI.0064-12.2012 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|